GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » E10

North China Pharmaceutical Co (SHSE:600812) E10 : ¥0.00 (As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

North China Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was ¥0.031. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.00 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of North China Pharmaceutical Co was 58.70% per year. The lowest was -26.30% per year. And the median was 7.70% per year.

As of today (2024-09-25), North China Pharmaceutical Co's current stock price is ¥4.82. North China Pharmaceutical Co's E10 for the quarter that ended in Jun. 2024 was ¥0.00. North China Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of North China Pharmaceutical Co was 1066.51. The lowest was 71.67. And the median was 139.62.


North China Pharmaceutical Co E10 Historical Data

The historical data trend for North China Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co E10 Chart

North China Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.06 - - -

North China Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of North China Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, North China Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


North China Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, North China Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where North China Pharmaceutical Co's Shiller PE Ratio falls into.



North China Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, North China Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.031/114.7809*114.7809
=0.031

Current CPI (Jun. 2024) = 114.7809.

North China Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201409 0.004 98.900 0.005
201412 0.015 99.000 0.017
201503 0.011 99.900 0.013
201506 0.010 99.500 0.012
201509 -0.002 100.500 -0.002
201512 0.020 100.600 0.023
201603 0.009 102.200 0.010
201606 0.009 101.400 0.010
201609 0.022 102.400 0.025
201612 -0.007 102.600 -0.008
201703 0.008 103.200 0.009
201706 0.011 103.100 0.012
201709 -0.006 104.100 -0.007
201712 -0.001 104.500 -0.001
201803 0.016 105.300 0.017
201806 0.022 104.900 0.024
201809 0.009 106.600 0.010
201812 0.045 106.500 0.048
201903 0.019 107.700 0.020
201906 0.030 107.700 0.032
201909 0.007 109.800 0.007
201912 0.050 111.200 0.052
202003 0.041 112.300 0.042
202006 0.033 110.400 0.034
202009 0.012 111.700 0.012
202012 -0.028 111.500 -0.029
202103 -0.035 112.662 -0.036
202106 0.034 111.769 0.035
202109 0.010 112.215 0.010
202112 0.000 113.108 0.000
202203 0.008 114.335 0.008
202206 0.011 114.558 0.011
202209 0.003 115.339 0.003
202212 -0.424 115.116 -0.423
202303 0.003 115.116 0.003
202306 0.012 114.558 0.012
202309 0.001 115.339 0.001
202312 -0.013 114.781 -0.013
202403 0.011 115.227 0.011
202406 0.031 114.781 0.031

Add all the adjusted EPS together and divide 10 will get our e10.


North China Pharmaceutical Co  (SHSE:600812) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of North China Pharmaceutical Co was 1066.51. The lowest was 71.67. And the median was 139.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


North China Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


North China Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director

North China Pharmaceutical Co Headlines

No Headlines